1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

ABCL - 1574

Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

Imran Khan

Poster Presenter: Imran Khan

ABCL - 1583

Real-world propensity score matched outcomes of CAR-T therapy in patients aged =65 years versus 18-64 years with DLBCL

Milan Regmi

Poster Presenter: Milan Regmi

Thumbnail for Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

ABCL - 1584

Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

Muhammad Sarfraz Khan

Poster Presenter: Muhammad Sarfraz Khan

Thumbnail for Venous Thromboembolism Is Associated With Greater 90-Day Morbidity and Inpatient Utilization Among Hospitalized Patients With Diffuse Large B-Cell Lymphoma: A Propensity-Matched TriNetX Analysis

ABCL - 1615

Venous Thromboembolism Is Associated With Greater 90-Day Morbidity and Inpatient Utilization Among Hospitalized Patients With Diffuse Large B-Cell Lymphoma: A Propensity-Matched TriNetX Analysis

Mevlut Ozmen

Poster Presenter: Mevlut Ozmen

$Thumbnail for CD20ΧCD3 Bispecific Antibodies in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy and Immune Toxicity$

ABCL - 1629

CD20ΧCD3 Bispecific Antibodies in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy and Immune Toxicity

Sri Pranita Cherukuri

Poster Presenter: Sri Pranita Cherukuri

Thumbnail for Diffusing the Double-Hit: A Tabular Diffusion Meta-Analysis Generating Counterfactual Survival Trajectories for MYC/BCL2 Double-Hit Lymphoma

ABCL - 1630

Diffusing the Double-Hit: A Tabular Diffusion Meta-Analysis Generating Counterfactual Survival Trajectories for MYC/BCL2 Double-Hit Lymphoma

Raj Nandan Chennuri

Poster Presenter: Raj Nandan Chennuri

$Thumbnail for Cardiovascular Adverse Event Reporting Patterns With CD19 CAR-T and CD20ΧCD3 Bispecific Antibodies in Relapsed/Refractory Large B-Cell Lymphoma: A FAERS Disproportionality Analysis$

ABCL - 1635

Cardiovascular Adverse Event Reporting Patterns With CD19 CAR-T and CD20ΧCD3 Bispecific Antibodies in Relapsed/Refractory Large B-Cell Lymphoma: A FAERS Disproportionality Analysis

Bailey Grones

Poster Presenter: Bailey Grones

Thumbnail for Sociodemographic Disparities in DLBCL Mortality in the United States During the Modern Therapeutic Era: A CDC Wonder Analysis, 1999-2024

ABCL - 1647

Sociodemographic Disparities in DLBCL Mortality in the United States During the Modern Therapeutic Era: A CDC Wonder Analysis, 1999-2024

Ahsun Siddiqi

Poster Presenter: Ahsun Siddiqi

Thumbnail for Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis

ABCL - 1652

Impact of Diabetes Mellitus on Outcomes and Toxicity in Patients With Diffuse Large B-Cell Lymphoma Treated With Bispecific Antibodies: A Real-World Propensity Score-Matched Analysis

Juhi Ardeshna-Chovatiya

Poster Presenter: Juhi Ardeshna-Chovatiya